SCHIRINZI, TOMMASO
 Distribuzione geografica
Continente #
NA - Nord America 17.204
AS - Asia 3.601
EU - Europa 2.751
Continente sconosciuto - Info sul continente non disponibili 580
SA - Sud America 558
AF - Africa 64
OC - Oceania 8
Totale 24.766
Nazione #
US - Stati Uniti d'America 16.943
SG - Singapore 1.634
IT - Italia 1.104
CN - Cina 572
BR - Brasile 439
RU - Federazione Russa 363
HK - Hong Kong 335
VN - Vietnam 280
IE - Irlanda 221
BD - Bangladesh 218
DE - Germania 192
KR - Corea 186
GB - Regno Unito 153
CA - Canada 136
UA - Ucraina 134
FR - Francia 128
JP - Giappone 120
NL - Olanda 103
SE - Svezia 83
FI - Finlandia 79
IN - India 67
PL - Polonia 49
AR - Argentina 46
MX - Messico 42
ID - Indonesia 35
AT - Austria 34
ZA - Sudafrica 29
TR - Turchia 21
EC - Ecuador 20
IQ - Iraq 20
ES - Italia 18
CO - Colombia 17
JO - Giordania 16
JM - Giamaica 13
CR - Costa Rica 12
PK - Pakistan 11
VE - Venezuela 11
AL - Albania 10
CH - Svizzera 10
BE - Belgio 9
KG - Kirghizistan 9
MY - Malesia 9
SV - El Salvador 9
LT - Lituania 8
MA - Marocco 8
PT - Portogallo 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
NI - Nicaragua 7
PH - Filippine 7
TH - Thailandia 7
AU - Australia 6
CL - Cile 6
CZ - Repubblica Ceca 6
KE - Kenya 6
PR - Porto Rico 6
RS - Serbia 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
EG - Egitto 5
HN - Honduras 5
HR - Croazia 5
IR - Iran 5
PE - Perù 5
PY - Paraguay 5
TN - Tunisia 5
UY - Uruguay 5
CW - ???statistics.table.value.countryCode.CW??? 4
DK - Danimarca 4
EE - Estonia 4
EU - Europa 4
GR - Grecia 4
GT - Guatemala 4
IL - Israele 4
NP - Nepal 4
AZ - Azerbaigian 3
BO - Bolivia 3
NO - Norvegia 3
PS - Palestinian Territory 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BS - Bahamas 2
GD - Grenada 2
GE - Georgia 2
GP - Guadalupe 2
LC - Santa Lucia 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
RO - Romania 2
SC - Seychelles 2
SI - Slovenia 2
SN - Senegal 2
TC - Turks e Caicos 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
BB - Barbados 1
BM - Bermuda 1
Totale 24.176
Città #
Wilmington 3.524
Houston 3.132
Woodbridge 2.642
Singapore 893
Ashburn 890
San Jose 630
Fairfield 535
Chandler 363
Hong Kong 332
Council Bluffs 294
Rome 290
Seattle 232
Ann Arbor 231
Beijing 201
New York 195
Cambridge 188
Dublin 187
Santa Clara 172
Dallas 140
Los Angeles 136
The Dalles 133
Medford 129
Tokyo 117
Dearborn 110
Milan 97
Jacksonville 96
North Bergen 93
Hanoi 86
Ho Chi Minh City 86
Buffalo 70
Denver 69
Lawrence 61
Lauterbourg 58
São Paulo 48
Menlo Park 45
Moscow 42
Chicago 40
Helsinki 39
Toronto 38
Munich 37
Orem 32
Brooklyn 31
Montreal 30
London 29
Nuremberg 29
Phoenix 28
Carrboro 26
Warsaw 26
Atlanta 24
Redondo Beach 24
Naples 23
San Diego 23
Johannesburg 21
Mexico City 21
Stockholm 20
Boardman 19
Chennai 19
Frankfurt am Main 19
Bologna 18
Kraków 18
Zhengzhou 18
Shanghai 17
Shenzhen 17
Amsterdam 16
Nanjing 16
Norwalk 16
Amman 15
Boston 15
Colorado Springs 15
Jakarta 15
Seoul 15
Detroit 14
Florence 14
Kunming 14
Lappeenranta 14
Manchester 14
Philadelphia 14
Rio de Janeiro 14
Salt Lake City 14
Hillsboro 13
Miami 13
Newark 13
Poplar 13
Bari 12
Columbus 12
Del Norte 12
Hefei 12
Monmouth Junction 12
San Francisco 12
Verona 12
Vienna 12
Catania 11
Durham 11
Incheon 11
Creede 10
Da Nang 10
Guangzhou 10
Mountain View 10
Palermo 10
Paris 10
Totale 17.709
Nome #
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 636
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 518
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain 516
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 502
Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia 490
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 472
Occurrence of Writing Tremor in Patients With Scans Without Evidence of Dopaminergic Deficit 463
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 459
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 454
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 454
Impaired intracortical transmission in G2019S leucine rich-repeat kinase Parkinson patients 447
Centrality of striatal cholinergic transmission in Basal Ganglia function 445
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 444
PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity 442
CSF biomarkers in superficial siderosis: a new tool for diagnosis and evaluation of therapeutic efficacy of deferiprone--a case report 436
Double hit mouse model of Parkinson's disease 433
Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia 421
Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission. 418
Outlining a population "at risk" of Parkinson's disease: Evidence from a case-control study 414
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence 395
Centrality of early synaptopathy in Parkinson's disease 387
Transient parkinsonism after unilateral midbrain stroke: a compensatory intervention from the healthy side? 378
Dopaminergic involvement in a drummer with focal dystonia: A case study 338
Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus 332
Promising rodent models in Parkinson's disease 328
Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case report 325
Assessment of serum uric acid as risk factor for tauopathies 324
Association between physical activity and dementia’s risk factors in patients with Parkinson’s disease 311
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 309
Comments on: “Complementary and alternative therapies for restless legs syndrome: An evidence-based systematic review” 292
Long-term treatment with rotigotine in drug-naïve PSP patients 289
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease 280
Effectiveness of robot-assisted gait training on motor impairments in people with Parkinson's disease: A systematic review and meta-analysis 279
The effect of postural deformities on back function and pain in patients with Parkinson's disease 275
Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy 271
Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction 270
CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients 270
Dystonia as a network disorder: A concept in evolution 253
Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical features 239
Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease 231
Assessment of Psychometric Characteristics of Parkinson’s Disease Sleep Scale 2 and Analysis of a Cut-Off Score for Detecting Insomnia in Italian Patients with Parkinson’s Disease: A Validation Study 223
Cerebrospinal fluid ferritin and siderophages in the diagnosis of superficial cerebral siderosis 219
Systemic activation of Nrf2 pathway in Parkinson's disease 213
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease. 204
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease 203
A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms 196
Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer's Disease: From Animal Models to the Human Pathology 195
Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease 177
Sex hormones differentially contribute to Parkinson disease in males: a multimodal biomarker study 176
Technology-based assessment of motor impairment in de novo Parkinson's disease patients: implications for diagnostic accuracy and early identification of distinct phenotypes 174
The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia 164
The influence of postural deformities on neck function and pain in patients with Parkinson's disease 159
Adult-onset sporadic chorea: real-world data from a single-centre retrospective study 149
Transcranial Direct Current Stimolation (tDCS) on PD Patients with Freezing of Gait: Preliminary Findings 144
Band-Specific Altered Cortical Connectivity in Early Parkinson's Disease and its Clinical Correlates 142
Circulating calprotectin as a potential biomarker of persistent olfactory dysfunctions in Post-COVID-19 patients 142
Spinal vascular lesions: anatomy, imaging techniques and treatment 142
Insular and limbic abnormal functional connectivity in early-stage Parkinson’s disease patients with autonomic dysfunction 138
Axial postural abnormalities and pain in Parkinson's disease 136
Cortical functional connectivity changes in the body-first and brain-first subtypes of Parkinson's disease 135
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 130
Hearing dysfunction heralds an increase in non-motor burden and a worse quality of life in Parkinson’s disease: new insights from non-motor spectrum 128
Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear Palsy 128
Ischemic injury precipitates neuronal vulnerability in Parkinson{'}s disease: Insights from PINK1 mouse model study and clinical retrospective data 126
Physical activity changes and correlate effects in patients with Parkinson's disease during COVID-19 lockdown 125
Sex hormones shape EEG-based functional connectivity in early-stage Parkinson’s disease patients 123
STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson's Disease 123
Clinical course of paroxysmal dyskinesias throughout pregnancy 119
Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy 119
Neuroimaging findings in leukoencephalopathy with calcifications and cysts: case report and review of the literature 117
Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort 117
Early Alterations in De Novo Parkinson’s Disease Revealed by Diffusion Tensor Imaging: Preliminary Study 116
Neutrophil-to-lymphocyte ratio and lymphocyte count reflect alterations in central neurodegeneration-associated proteins and clinical severity in Parkinson Disease patients 116
COVID-19: dealing with a potential risk factor for chronic neurological disorders 114
Olfactory Neuron Substance P is Overexpressed in Parkinson's Disease Reflecting Gut Dysfunction 113
Contribution of testosterone and estradiol in sexual dimorphism of early-onset Parkinson's disease 113
Gastrointestinal Dysfunction Bears on the Clinical‐Biological Profile of Parkinson's Disease 112
Motor cortex transcranial direct current stimulation improves non-motor symptoms in early-onset Parkinson’s disease: a pilot study 109
Validation of the Italian version of the PSP Quality of Life questionnaire 109
Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease 107
Parkinson's disease motor progression in relation to the timing of REM sleep behavior disorder presentation: an exploratory retrospective study 107
Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG 105
Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway 104
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction 103
A biological characterization of patients with postmenopausal Parkinson's disease 102
Constipation distinguishes different clinical-biochemical patterns in de novo Parkinson's disease 101
Increased blood-brain barrier permeability is associated with dysfunctional α band connectivity in early-stage Parkinson’s disease 100
Short‐Term Effects of Continuous Theta Burst Stimulation in Treating a Young Patient Affected by Post‐Ischemic Hemidystonia 99
Biofluids profile of ?-Klotho in patients with Parkinson{'}s disease 99
Movement disorders in primary central nervous system lymphoma: two unreported cases and a review of literature 98
Tau and Amyloid-beta Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters 97
Peripheral immunity changes are associated with neurodegeneration and worse clinical outcome in idiopathic normal pressure hydrocephalus 97
Increase of Prokineticin-2 in Serum of Patients with Parkinson{'}s Disease 95
Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study 94
Pattern of Mitochondrial Respiration in Peripheral Blood Cells of Patients with Parkinson's Disease 92
Stage-dependent phosphoproteome remodeling of Parkinson's disease blood cells 91
Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson’s disease 90
Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease. 88
Effects of head trauma and sport participation in young-onset Parkinson?s disease 86
Prevenzione del rischio di disturbo muscoloscheletrico in lavoratori videoterminalisti affetti da Malattia di Parkinson. Studio ergonomico e riabilitativo 85
Totale 22.968
Categoria #
all - tutte 76.743
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.743


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022641 0 0 0 40 6 63 143 41 38 64 72 174
2022/2023935 98 84 29 104 74 210 131 74 75 1 37 18
2023/2024532 41 14 24 12 51 113 31 71 16 52 24 83
2024/20252.790 58 505 224 146 86 279 193 227 239 292 312 229
2025/20265.449 392 191 595 426 454 207 627 637 517 634 485 284
2026/20272.611 474 344 990 803 0 0 0 0 0 0 0 0
Totale 24.766